Freestone Grove Partners’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-36,126
Closed -$45.9K 644
2024
Q4
$45.9K Buy
+36,126
New +$45.9K ﹤0.01% 569